Home
Conditions
Phase 1

Clinical trial condition

Phase 1

Explore clinical trials studying Phase 1. Study availability and eligibility vary by location and protocol.

19 public trials 4 recruiting studies

Refine in advanced search Browse all conditions

Phase 1 trial results

Completed

A Phase 1 Study of NOV1601(CHC2014) in Adult Subjects With Solid Organ Malignancies

NCT04014257

Conditions: Phase 1, Solid Tumor, Adult
Locations: National Cancer Center Goyang-si, Gyeonggi-do, South Korea

CHA Bundang Medical Center Seongnam-si, Gyeonggi-do, South Korea

Seoul National University Hospital Seoul, South Korea

Severance Hospital Seoul, South Korea

View Trial Details

Completed

A Study to Determine the Effects of PF-04965842 on Midazolam PK in Healthy Volunteers

NCT03647670

Conditions: Phase 1
Locations: Pfizer Clinical Research Unit Brussels, Belgium

View Trial Details

Completed

Safety Study of Dengushield in Healthy Adults

NCT03883620

Conditions: Arbovirus Infections, Dengue, Flaviviridae Infections, +8 more
Locations: CMAX Clinical Research Pty Ltd Adelaide, South Australia, Australia

View Trial Details

Completed

A Study In Healthy People Of Multiple Doses Of UK-396,082 Given By Mouth, To Investigate The Safety, Toleration And Time Course Of Blood Concentration Of UK-396,082 And Its Effects.

NCT01091532

Conditions: Multiple Dose, Pharmacokinetic, Phase 1, +2 more
Locations: Pfizer Investigational Site Brussels, Belgium

View Trial Details

Completed

A Study Of CinnoRA (Adalimumab-CinnaGen) And Adalimumab (Humira) In Healthy Subjects

NCT03273192

Conditions: Bioequivalence, Phase 1
Locations: Orchidpharmed PK/PD site Tehran, Iran

View Trial Details

Completed

Pharmacokinetic, Safety and Tolerability Study of Altebrel in Healthy Male Subjects

NCT03273088

Conditions: Bioequivalence, Phase 1
Locations: Orchidpharmed PK/PD site Tehrān, Tehran Province, Iran

View Trial Details

Completed

EC905 Pharmacokinetic Profile Study

NCT02634489

Conditions: Benign Prostatic Hyperplasia, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +20 more
Locations: Site NL1 Zuidlaren, Drenthe, Netherlands

View Trial Details

Completed

A Study to Compare How Much Solifenacin Succinate and Mirabegron Reach the Blood When Administered Together as Fixed-dose Combination Tablets and With Single Individual Tablets of the Same Medications at Three Dose Levels

NCT02010944

Conditions: Bioavailability, Healthy Subjects, Phase 1
Locations: Parexel Berlin, Germany

View Trial Details

Completed

A First In Human Study In Healthy People To Evaluate Safety, Toleration And Time Course Of Plasma Concentration Of Single Inhaled Doses Of PF-05212372.

NCT01415102

Conditions: Pharmacokinetics, Phase 1, Safety, +2 more
Locations: Pfizer Investigational Site Brussels, Belgium

View Trial Details

Phase 1

Phase 1 trial results

Related conditions